Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1572-8595
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation ; day:3 ; month:8 ; year:2018 ; pages:1-6
Journal of interventional cardiac electrophysiology ; (3.8.2018), 1-6
- Creator
-
De Heide, John
- Contributor
-
Vroegh, Christiaan J.
Bhagwandien, Rohit E.
Wijchers, Sip A.
Szili-Torok, Tamas
Zijlstra, Felix
Lenzen, Mattie J.
Yap, S. C.
SpringerLink (Online service)
- DOI
-
10.1007/s10840-018-0417-0
- URN
-
urn:nbn:de:101:1-2018100521353289143619
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- De Heide, John
- Vroegh, Christiaan J.
- Bhagwandien, Rohit E.
- Wijchers, Sip A.
- Szili-Torok, Tamas
- Zijlstra, Felix
- Lenzen, Mattie J.
- Yap, S. C.
- SpringerLink (Online service)
Other Objects (12)
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
Images Interrupted
Interrupted Suite
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
Images Interrupted
Interrupted Suite
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
Images Interrupted